Literature DB >> 26277275

Metabolic regulation of T cell differentiation and function.

Benjamin V Park1, Fan Pan2.   

Abstract

Upon encountering pathogens, T cells mount immune responses by proliferating, increasing cellular mass and differentiating. These cellular changes impose significant energetic challenges on T cells. It was believed that TCR and cytokine-mediated signaling are dominant dictators of T cell-mediated immune responses. Recently, it was recognized that T cells utilize metabolic transporters and metabolic sensors that allow them to rapidly respond to nutrient-limiting inflammatory environments. Metabolic sensors allow T cells to find a balance between energy consumption (anabolic metabolism) and production (catabolic metabolism) in order to mount effective immune responses. Also, metabolic regulators interact with cytokine-dependent transcriptional regulators, suggesting a more integrative and advanced model of T cell activation and differentiation. In this review, we will discuss recent discoveries regarding the roles of metabolic regulators in effector and memory T cell development and their interaction with canonical transcription factors.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aerobic glycolysis; Anabolic metabolism; Catabolic metabolism; Differentiation; Effector and memory T cells; Fatty acid oxidation; Proliferation; TCA cycle; Treg

Mesh:

Year:  2015        PMID: 26277275      PMCID: PMC4729201          DOI: 10.1016/j.molimm.2015.07.027

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  128 in total

1.  On respiratory impairment in cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-08-10       Impact factor: 47.728

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

3.  Cutting edge: hypoxia-inducible factor 1alpha and its activation-inducible short isoform I.1 negatively regulate functions of CD4+ and CD8+ T lymphocytes.

Authors:  Dmitriy Lukashev; Boris Klebanov; Hidefumi Kojima; Alex Grinberg; Akiko Ohta; Ludmilla Berenfeld; Roland H Wenger; Akio Ohta; Michail Sitkovsky
Journal:  J Immunol       Date:  2006-10-15       Impact factor: 5.422

4.  Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells.

Authors:  D Tzachanis; G J Freeman; N Hirano; A A van Puijenbroek; M W Delfs; A Berezovskaya; L M Nadler; V A Boussiotis
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

Review 5.  Metformin: from mechanisms of action to therapies.

Authors:  Marc Foretz; Bruno Guigas; Luc Bertrand; Michael Pollak; Benoit Viollet
Journal:  Cell Metab       Date:  2014-10-30       Impact factor: 27.287

6.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

Authors:  Ruoning Wang; Christopher P Dillon; Lewis Zhichang Shi; Sandra Milasta; Robert Carter; David Finkelstein; Laura L McCormick; Patrick Fitzgerald; Hongbo Chi; Joshua Munger; Douglas R Green
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

7.  Anergic T cells are metabolically anergic.

Authors:  Yan Zheng; Greg M Delgoffe; Christian F Meyer; Waipan Chan; Jonathan D Powell
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

8.  Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa.

Authors:  Eric T Clambey; Eóin N McNamee; Joseph A Westrich; Louise E Glover; Eric L Campbell; Paul Jedlicka; Edwin F de Zoeten; John C Cambier; Kurt R Stenmark; Sean P Colgan; Holger K Eltzschig
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205

9.  De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells.

Authors:  Luciana Berod; Christin Friedrich; Amrita Nandan; Jenny Freitag; Stefanie Hagemann; Kirsten Harmrolfs; Aline Sandouk; Christina Hesse; Carla N Castro; Heike Bähre; Sarah K Tschirner; Nataliya Gorinski; Melanie Gohmert; Christian T Mayer; Jochen Huehn; Evgeni Ponimaskin; Wolf-Rainer Abraham; Rolf Müller; Matthias Lochner; Tim Sparwasser
Journal:  Nat Med       Date:  2014-10-05       Impact factor: 53.440

10.  PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells.

Authors:  David K Finlay; Ella Rosenzweig; Linda V Sinclair; Carmen Feijoo-Carnero; Jens L Hukelmann; Julia Rolf; Andrey A Panteleyev; Klaus Okkenhaug; Doreen A Cantrell
Journal:  J Exp Med       Date:  2012-11-26       Impact factor: 14.307

View more
  15 in total

Review 1.  Cancer Cell Metabolism: Implications for X-ray and Particle Radiation Therapy.

Authors:  Mathieu Sertorio; John P Perentesis; Ralph E Vatner; Anthony E Mascia; Yi Zheng; Susanne I Wells
Journal:  Int J Part Ther       Date:  2018-09-21

Review 2.  Metabolic Factors that Contribute to Lupus Pathogenesis.

Authors:  Wei Li; Ramya Sivakumar; Anton A Titov; Seung-Chul Choi; Laurence Morel
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

Review 3.  Obesity altered T cell metabolism and the response to infection.

Authors:  William D Green; Melinda A Beck
Journal:  Curr Opin Immunol       Date:  2017-03-27       Impact factor: 7.486

4.  Metabolic and functional impairment of CD8+ T cells from the lungs of influenza-infected obese mice.

Authors:  William D Green; Abrar E Al-Shaer; Qing Shi; Kymberly M Gowdy; Nancie J MacIver; J Justin Milner; Melinda A Beck; Saame Raza Shaikh
Journal:  J Leukoc Biol       Date:  2021-04-13       Impact factor: 4.962

5.  Epidermal Fatty Acid Binding Protein (E-FABP) Is Not Required for the Generation or Maintenance of Effector and Memory T Cells following Infection with Listeria monocytogenes.

Authors:  Bing Li; Nathan W Schmidt
Journal:  PLoS One       Date:  2016-09-02       Impact factor: 3.240

6.  Cyp1b1-mediated suppression of lymphoid progenitors in bone marrow by polycyclic aromatic hydrocarbons coordinately impacts spleen and thymus: a selective role for the Ah Receptor.

Authors:  Michele Campaigne Larsen; Alhaji U N'Jai; David L Alexander; Catherine M Rondelli; E C Forsberg; Charles J Czuprynski; Colin R Jefcoate
Journal:  Pharmacol Res Perspect       Date:  2016-07-29

Review 7.  Metabolism Controls the Balance of Th17/T-Regulatory Cells.

Authors:  Licheng Sun; Jinrong Fu; Yufeng Zhou
Journal:  Front Immunol       Date:  2017-11-27       Impact factor: 7.561

8.  Cobra Venom Factor and Ketoprofen Abolish the Antitumor Effect of Nerve Growth Factor from Cobra Venom.

Authors:  Alexey V Osipov; Tatiana I Terpinskaya; Tatiana E Kuznetsova; Elena L Ryzhkovskaya; Vladimir S Lukashevich; Julia A Rudnichenko; Vladimir S Ulashchyk; Vladislav G Starkov; Yuri N Utkin
Journal:  Toxins (Basel)       Date:  2017-09-06       Impact factor: 4.546

Review 9.  The Alterations in and the Role of the Th17/Treg Balance in Metabolic Diseases.

Authors:  Siwen Zhang; Xiaokun Gang; Shuo Yang; Mengzhao Cui; Lin Sun; Zhuo Li; Guixia Wang
Journal:  Front Immunol       Date:  2021-07-12       Impact factor: 7.561

10.  Antimetabolite TTL-315 selectively kills glucose-deprived cancer cells and enhances responses to cytotoxic chemotherapy in preclinical models of cancer.

Authors:  James DuHadaway; George C Prendergast
Journal:  Oncotarget       Date:  2016-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.